Table 3.
Percentage of common mRNAs and long non-coding RNAs (lncRNAs) in SEVs and LEVs in AD, FTD, ALS, and PD.
| mRNAs | ||
|---|---|---|
| Common mRNAs in SEVs and LEVs (%) | ||
| SEVs | LEVs | |
| AD | 0 | 0 |
| FTD | 17.1 | 34.2 |
| ALS | 8.4 | 35.5 |
| PD | 0 | 0 |
| lncRNAs | ||
| Common lncRNAs in SEVs and LEVs (%) | ||
| SEVs | LEVs | |
| AD | 0 | 0 |
| FTD | 33.3 | 21.1 |
| ALS | 66.7 | 54.5 |
| PD | 0 | 0 |
AD, Alzheimer's disease; FTD, fronto-temporal dementia; ALS, amyotrophic lateral sclerosis; PD, Parkinson's disease; CTRs, controls; SEVs, small extracellular vesicles; LEVs, large extracellular vesicles; mRNAs, messangerRNAs; lncRNAs, long non-coding RNA.